AAAAAA

   
Results: 1-8 |
Results: 8
A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model andimaging of neuroblastoma patients
Authors: Hoefnagel, CA Rutgers, M Buitenhuis, CKM Smets, LA de Kraker, J Meli, M Carrel, F Amstutz, H Schubiger, PA Novak-Hofer, I
Citation: Ca. Hoefnagel et al., A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model andimaging of neuroblastoma patients, EUR J NUCL, 28(3), 2001, pp. 359-368
[I-131]- and [I-125]Metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: A comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts
Authors: Rutgers, M Buitenhuis, CKM van der Valk, MA Hoefnagel, CA Voute, PA Smets, LA
Citation: M. Rutgers et al., [I-131]- and [I-125]Metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: A comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts, INT J CANC, 90(6), 2000, pp. 312-325
Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: Tissue distribution, metabolism and therapeutic efficacy
Authors: Rutgers, M Buitenhuis, CKM Hoefnagel, CA Voute, PA Smets, LA
Citation: M. Rutgers et al., Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: Tissue distribution, metabolism and therapeutic efficacy, INT J CANC, 87(3), 2000, pp. 412-422
Signalling steps in apoptosis by ether lipids
Authors: Smets, LA Van Rooij, H Salomons, GS
Citation: La. Smets et al., Signalling steps in apoptosis by ether lipids, APOPTOSIS, 4(6), 1999, pp. 419-427
Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome
Authors: Salomons, GS Smets, LA Verwijs-Janssen, M Hart, AAM Haarman, EG Kaspers, GJL Van Wering, ER Van Der Does-Van Den Berg, A Kamps, WA
Citation: Gs. Salomons et al., Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome, LEUKEMIA, 13(10), 1999, pp. 1574-1580
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analoguebenzylguanidine (BG)
Authors: Kuin, A Aalders, M Lamfers, M van Zuidam, DJ Essers, M Beijnen, JH Smets, LA
Citation: A. Kuin et al., Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analoguebenzylguanidine (BG), BR J CANC, 79(5-6), 1999, pp. 793-801
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)
Authors: Kuin, A Rutgers, M van der Valk, MA Beijnen, JH Smets, LA
Citation: A. Kuin et al., Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG), BR J CANC, 79(5-6), 1999, pp. 802-806
Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991)
Authors: Kamps, WA Bokkerink, JPM Hahlen, K Hermans, J Riehm, H Gadner, H Schrappe, M Slater, R van den Berg-de Ruiter, E Smets, LA de Vaan, GAM Weening, RS van Weerden, JF van Wering, ER van der Does-van den Berg, A
Citation: Wa. Kamps et al., Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991), BLOOD, 94(4), 1999, pp. 1226-1236
Risultati: 1-8 |